tga bpc-157 approval status australia Australian Regulatory Process for Medical and IVD Devices This is a joint statement
This is a joint statement from the TGA and Australia's Chief Medical Officer on concerns regarding the public health risks associated with unapproved peptide products. Australia's health leaders are increasingly concerned about BPC 157 is showing up in orthopedic conversations because it is doing something the research has not fully caught up to yet. The short version is that BPC 157 is a synthetic peptide derived BPC 157 in Australia: Benefits, side effects, risks and legality As illegal peptide use in Australia continues to skyrocket, the TGA has formally deemed it such a risk to consumer safety it has made it a compliance priority for 2026 warning BPC 157 + TB 500 Blend Australia 10mg 20mg Optic Labs
Pay in 4 interest-free payments of $6.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

